‘Holy grail’ of gene therapy still a long way off for cystic fibrosis

Conventional treatments developed by Vertex help many sufferers, but they have a hefty price tag
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news